Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19

Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19

Source: 
Fierce Pharma
snippet: 

Pfizer and Bristol Myers Squibb are the latest drugmakers to join the swell of campaigns promoting doctor visits during the pandemic.

Focused on three health conditions—atrial fibrillation, deep vein thrombosis and pulmonary embolism, all treated by the partners' anticoagulant Eliquis—the BMS-Pfizer Alliance launched a campaign including TV ads to raise awareness and encourage people to seek prompt medical attention.